Skip to main content

Table 3 Oxidative stress and adipokines in diabetic patients with hyperglycemic crises before and after treatment and the healthy controls (x ± s)

From: Oxidative stress and adipokine levels were significantly correlated in diabetic patients with hyperglycemic crises

 

Control

DKA

NKH

Before treatment

After treatment

Before treatment

After treatment

SOD (kU/L)

89.56 ± 14.16

48.76 ± 18.33a

69.52 ± 16.31ab

53.52 ± 14.70a

70.35 ± 13.80ab

MDA (µmol/L)

5.23 ± 2.57

11.37 ± 3.66a

7.64 ± 2.90ab

8.57 ± 3.01a

6.07 ± 2.67ab

TAC (kU/L)

29.51 ± 11.49

20.39 ± 10.61a

24.27 ± 10.05ab

20.95 ± 12.41a

23.02 ± 11.23ab

8-Iso-PGF2α (µg/L)

6.70 ± 2.33

18.42 ± 5.78a

15.14 ± 6.21ab

20.90 ± 4.70a

13.44 ± 6.71ab

Adiponectin (µg/L)

9.89 ± 1.63

5.77 ± 1.55a

7.12 ± 1.63ab

5.23 ± 1.11a

8.06 ± 1.56ab

Leptin (µg/L)

8.91 ± 1.73

6.07 ± 2.45a

8.45 ± 2.13b

5.91 ± 1.07a

8.78 ± 2.65

Restistin (µg/L)

3.21 ± 1.07

8.35 ± 1.83a

6.24 ± 1.50ab

9.23 ± 2.06a

7.14 ± 1.99ab

  1. DKA: diabetic ketoacidosis group; NKH: non-ketotic hyperglycemia group; control group: healthy individuals
  2. aP < 0.05, compared with controls
  3. bP < 0.05, compared with the same group before treatment